Application of various genetic analysis techniques for detecting two rare cases of 9p duplication mosaicism during prenatal diagnosis

• Published in: Molecular genetics & genomic medicine 2023-10, Vol.11 (10), p.e2229-e2229
• Main Authors: Zhang, Sufen, Zhou, Yuqiu, Xiao, Gefei, Qiu, Xianrong
• Format: Article
• Language: English
• Subjects: 9p duplication; Amniocentesis; Amniotic fluid; Cell culture; Childrens health; Chromosomes; Diagnosis; DNA microarrays; Fluorescence in situ hybridization; Genetic analysis; genetic analysis techniques; Genetic counseling; Genetic screening; Genomes; Hybridization; Hybridization analysis; Karyotypes; Literature reviews; Maternal & child health; Mosaicism; Original; Phenotypes; Pregnancy; Prenatal diagnosis; Tetrasomy; Trisomy; Ultrasonic imaging; Ultrasonic testing; Veins & arteries
• ISSN: 2324-9269; 2324-9269
• DOI: 10.1002/mgg3.2229

The identification of genetic mosaicism and the genetic counseling needed following its discovery have been challenging problems in the field of prenatal diagnosis. Herein, we describe the clinical phenotypes and various prenatal diagnostic processes used for two rare cases of 9p duplication mosaicism and review the prior literature in the field to evaluate the merits of different methods for diagnosing mosaic 9p duplication. We recorded ultrasound examinations, reported the screening and diagnosis pathways, and analyzed the mosaic levels of the two cases of 9p duplication using karyotype analysis, chromosomal microarray analysis (CMA), and fluorescence in situ hybridization analysis (FISH). Case 1 had a normal clinical phenotype for tetrasomy 9p mosaicism, and Case 2 showed multiple malformations caused by both trisomy 9 and trisomy 9p mosaicism. Both cases were initially suspected after non-invasive prenatal screening (NIPT) based on cell-free DNA. The mosaic ratio of 9p duplication found via karyotyping was lower than what was discovered by CMA and FISH, in both cases. Contrary to previous findings, the mosaic level of trisomy 9 found by karyotype analysis was greater than what was found by CMA, in terms of complex mosaicism involving trisomy 9 and trisomy 9p, in Case 2. NIPT can indicate 9p duplication mosaicism during prenatal screening. Different strengths and limitations existed in terms of diagnosing mosaic 9p duplication by karyotype analysis, CMA, and FISH. The combined use of various methods may be capable of more accurately determining break-points and mosaic levels of 9p duplication during prenatal diagnosis.